The GCF aims to support developing countries in achieving a paradigm shift to low-emission and climate-resilient pathways. This is achieved by funding innovative and transformative lowemission (mitigation) and climate-resilient (adaptation) projects and programmes developed by the public and private... sectors to contribute to the implementation of national climate change priorities in developing countries. While it is relatively easy to tell what a mitigation project or programme is (i.e. its contribution to the reduction of greenhouse gases in the atmosphere, and/or whether it increases the capacity of an ecosystem to absorb them), the blurred line between a general development project and an adaptation project has been a contentious issue in the international climate finance debate. The relevant question is not whether a project is (also) a development project, but whether the project contributes to adaptation (i.e. what the adaptation/additionality argument is).
This toolkit helps governments and project developers understand how to fulfil the Green Climate Fund’s requirements when developing a fully-fledged funding proposal.
more
Volume 20, September
Global smart update
Revised and expanded version of the Guidelines
To provide information on trends on official development assistance (ODA) disbursement patterns for
reproductive health activities in 18 conflict-affected countries
The Lancet, Planetary Health Volume 5, ISSUE 11, e766-e774, November 01, 2021
Increasing human demand for water and changes in water availability due to climate change threatens water security worldwide. Additionally, exploitation of water resources induces stress on freshwater environments, leadi...ng to biodiversity loss and reduced ecosystem services. We aimed to conduct a spatially detailed assessment of global human water stress for low to high environmental flow (EF) protection.
more
This study consists of a descriptive analysis of M. tuberculosis isolates from Beira Central Hospital, Mozambique, during 2014–2015, being the first report of a genotypic testing used to provide information about second line drug resistance in Mozambique.
BMC Infectious Diseases (2016) 16:423 DO...I 10.1186/s12879-016-1766-x
more
Ausgehend von allgemeinen Informationen zum Land über Hintergrundinformationen zum Konflikt (Wirtschaftskrise und politische Krise) werden auch die Menschenrechtsverletzungen durch die Regierung beschrieben. Der Bericht geht in diesem Zusammenhang auf die Aktivitäten der zahlreichen bewaffneten Gr...uppen (Armee, Sicherheitsdienste und "Colectivos") sowie die Rolle des staatlichen Öl- und Gaskonzerns Konzerns "PDVSA" ein. Schließlich behandelt er die Situation der Bevölkerung unter dem Blickwinkel des Zugangs zu sozialen Sicherungssystemen.
more
This training module is designed to equip HWs with knowledge and communication skills to build their confidence and support them in their ability to promote acceptance of COVID-19 vaccination among other HWs.
Disaster Recovery Toolkit
The Border Consortium (TBC) developed a comprehensive Training of Trainers Nutrition Curriculum which includes 12 Modules (6 Basic and 6 Advanced topics). The Manual provides trainers with standardized methods and content to deliver nutrition training.
Original file: 25 MB
A STUDY OF THE CHALLENGES FACED BY PERSONS WITH DISABILITIES IN POST-EARTHQUAKE
NEPAL.
“towards quality health and social welfare services”
The main objectives of the SOPs are to: (i) establish standards and timelines for response activities; and (ii) guide national governments and GPEI partners in key support functions.
This new version of the SOPs presents overall response requirements for dealing with type 1, 2 and 3 poliovirus fo...llowing monovalent type 2 oral polio vaccine (mOPV2) cessation. Version 2.4 will be valid until release of revised version 3.0 (anticipated May 2018).
more
Report of the Joint World Health Organization–Brien Holden Vision Institute Global Scientific Meeting on Myopia | University of New South Wales, Sydney, Australia 16–18 March 2015
Psychiatry and Pediatrics
Chapter I.5